LicianPro

RLYB stock

Rallybio Corp (RLYB) short interest & short volume · 0.2% of float short

Rallybio Corp official short interest (FINRA, twice monthly) and daily short volume (FINRA Reg SHO), with history, % of float and days to cover.

What changed

RLYB short interest fell 16.8% to 41K shares in the Oct 15, 2026 report (0.2% of float, 7.4 days to cover). Daily short volume averaged 35.6% of volume over the last 20 sessions, up from 30.1% the 20 sessions before, the 64th percentile of its own 20-day averages since Sep 23, 2025.

Short interest

Official, twice monthly · settled Oct 15, 2026

Shares short
41K
prior 49K
% of float
0.2%
float 19.7M
Days to cover
7.4
avg vol 6K
Change vs prior report
-16.8%

6 reports

The last 24 reports (about a year) with Lician Pro.Start 3-day trial — $149/yr

Days to cover is short interest divided by FINRA's average daily volume for the period: how many average days of trading it would take shorts to buy back.

% of float uses the current float for every report (no float was stored with older reports).

Source: FINRA equity short interest (twice monthly) · Settlement Oct 15, 2026

Daily short volume

Share of each day's volume sold short · FINRA Reg SHO

Latest (Nov 2)
48.1%
17K of 34K
20-day average
35.6%
prior 30.1%
Percentile vs own history
64th
233 periods since 2025

Loading prices…

Short volumeRest of the day's volume

Source: FINRA Reg SHO daily short sale volume · Latest Nov 2, 2026

Short squeeze score (model)

Price since settlement: -5.5%

Model, not a forecast: 40 pts short interest % of float (full at 30%), 25 pts days to cover (full at 10), 15 pts rise in short interest since the prior report (full at +50%), 20 pts price gain since the settlement date (full at +25%). Missing inputs score 0.

RLYB's squeeze score and its inputs with Lician Pro.Start 3-day trial — $149/yr

Market-wide: most shorted stocks, biggest changes and unusual short volume · RLYB overview

Last 10 sessions · daily short volume · FINRA Reg SHO
DateShortTotalShort % of volume
2026-11-0216,53734,36248.1%
2026-10-302,66325,55810.4%
2026-10-2922,25125,58487.0%
2026-10-283,8758,05148.1%
2026-10-277,77111,75666.1%
2026-10-261211,17310.3%
2026-10-236532,44826.7%
2026-10-227711,80442.7%
2026-10-214645,4468.5%
2026-10-2011848424.4%

Healthcare peers with similar quant ratings

RLYB among 532 rated Healthcare stocks (Lician quant rating, Nov 4, 2026). How the rating works

RLYB short interest FAQ

What is RLYB's short interest?

Rallybio Corp (RLYB) had 41K shares sold short and not yet covered in FINRA's Oct 15, 2026 settlement report, 0.2% of its 19.7M-share float.

How many days to cover does RLYB have?

7.4 days: 41K shares short divided by an average daily volume of 6K for the Oct 15, 2026 period.

Is RLYB short interest rising or falling?

RLYB short interest fell (-16.8%) from 49K to 41K shares in the Oct 15, 2026 report.

Is RLYB a short squeeze candidate?

Lician's squeeze watch scores RLYB 19 out of 100 (low) from the Oct 15, 2026 report: short interest % of float 0.3/40, days to cover 18.5/25, change in short interest vs prior report 0/15, price change since settlement date 0/20. It is a transparent model of how crowded the short side is, not a forecast that a squeeze will happen.

What share of RLYB daily volume is sold short?

35.6% on average over the last 20 sessions to Nov 2, 2026 (FINRA Reg SHO daily short volume; the 64th percentile of its own 20-day averages). Short volume counts market makers' same-day short sales, so it is not short interest.

What was RLYB's latest FINRA short volume?

On Nov 2, 2026, cached FINRA short volume for Rallybio Corp (RLYB) was 16,537 shares, 48.1% of 34,362 total volume.

How many RLYB short-volume sessions are listed on this page?

This page lists 10 cached FINRA short-volume sessions for Rallybio Corp (RLYB), from Oct 20, 2026 through Nov 2, 2026.

How did RLYB short volume percent change from the prior cached session?

Cached FINRA short volume for Rallybio Corp (RLYB) moved from 10.4% on Oct 30, 2026 to 48.1% on Nov 2, 2026, up 37.7 percentage points.

Not investment advice. Figures as filed or reported, not a live feed.